BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8416750)

  • 21. Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.
    de Vrij J; Uil TG; van den Hengel SK; Cramer SJ; Koppers-Lalic D; Verweij MC; Wiertz EJ; Vellinga J; Willemsen RA; Hoeben RC
    Gene Ther; 2008 Jul; 15(13):978-89. PubMed ID: 18323790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.
    Dutoit V; Rubio-Godoy V; Dietrich PY; Quiqueres AL; Schnuriger V; Rimoldi D; Liénard D; Speiser D; Guillaume P; Batard P; Cerottini JC; Romero P; Valmori D
    Cancer Res; 2001 Aug; 61(15):5850-6. PubMed ID: 11479225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
    Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
    Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.
    Gibbs P; Hutchins AM; Dorian KT; Vaughan HA; Davis ID; Silvapulle M; Cebon JS
    Melanoma Res; 2000 Jun; 10(3):259-64. PubMed ID: 10890380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.
    Chiari R; Foury F; De Plaen E; Baurain JF; Thonnard J; Coulie PG
    Cancer Res; 1999 Nov; 59(22):5785-92. PubMed ID: 10582700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry.
    Pascolo S; Schirle M; Gückel B; Dumrese T; Stumm S; Kayser S; Moris A; Wallwiener D; Rammensee HG; Stevanovic S
    Cancer Res; 2001 May; 61(10):4072-7. PubMed ID: 11358828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
    Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
    Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New tumour-restricted melanoma antigens as defined by cytotoxic T-cell responses.
    Parmiani G; Anichini A; Castelli C
    Melanoma Res; 1997 Aug; 7 Suppl 2():S95-8. PubMed ID: 9578423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of A, G and B melanoma antigen genes in human hepatocellular carcinoma.
    Chen Z; Shao JB; Wu W
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):570-3. PubMed ID: 14607688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients.
    Takahashi T; Irie RF; Morton DL; Hoon DS
    Cell Immunol; 1997 Jun; 178(2):162-71. PubMed ID: 9225007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.
    Zhang XM; Zhang YF; Huang Y; Qu P; Ma B; Si SY; Li ZS; Li WX; Li X; Ge W; Hu PZ; Sui YF
    Oncol Rep; 2008 Jul; 20(1):245-52. PubMed ID: 18575744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
    Gaugler B; Van den Eynde B; van der Bruggen P; Romero P; Gaforio JJ; De Plaen E; Lethé B; Brasseur F; Boon T
    J Exp Med; 1994 Mar; 179(3):921-30. PubMed ID: 8113684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2.
    Ma W; Germeau C; Vigneron N; Maernoudt AS; Morel S; Boon T; Coulie PG; Van den Eynde BJ
    Int J Cancer; 2004 May; 109(5):698-702. PubMed ID: 14999777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
    Traversari C; van der Bruggen P; Luescher IF; Lurquin C; Chomez P; Van Pel A; De Plaen E; Amar-Costesec A; Boon T
    J Exp Med; 1992 Nov; 176(5):1453-7. PubMed ID: 1402688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy.
    Oaks MK; Hanson JP; O'Malley DP
    Cancer Res; 1994 Apr; 54(7):1627-9. PubMed ID: 8137270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and analysis of MAGE-1-related genes.
    Ding M; Beck RJ; Keller CJ; Fenton RG
    Biochem Biophys Res Commun; 1994 Jul; 202(1):549-55. PubMed ID: 8037761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Establishment of B16-HLA-MAGE-3 melanoma cell line coexpressing HLA-A 0201/K(b) and MAGE-3 and its role in tumor vaccine evaluation].
    Song SX; Yan CZ; Zheng L; You HY; Wang JX; Liu FY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):679-82. PubMed ID: 18616910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression spectrum and methylation-dependent regulation of melanoma antigen-encoding gene family members in pancreatic cancer cells.
    Bert T; Lubomierski N; Gangsauge S; Münch K; Printz H; Prasnikar N; Robbel C; Simon B
    Pancreatology; 2002; 2(2):146-54. PubMed ID: 12123095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide.
    Salgaller ML; Weber JS; Koenig S; Yannelli JR; Rosenberg SA
    Cancer Immunol Immunother; 1994 Aug; 39(2):105-16. PubMed ID: 7519125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma-associated antigen genes - an update.
    Sang M; Wang L; Ding C; Zhou X; Wang B; Wang L; Lian Y; Shan B
    Cancer Lett; 2011 Mar; 302(2):85-90. PubMed ID: 21093980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.